Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed CNS Involvement by Lymphoma

NCT02724904 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02724904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02724904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed CNS Involvement by Lymphoma
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1/2
Overall status
Withdrawn
Start date
May 31, 2017
Completion date
December 31, 2021
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma